1 Oct 2026Jagsonpal Pharmaceuticals Ltd completes acquisition of Wellness Portfolio of Group Pharmaceuticals Limited on 01 Oct 2026Restructuring
23 Sept 2026Jagsonpal Pharmaceuticals Ltd acquires Wellness Portfolio of Group Pharmaceuticals for up to ₹46.7 Cr via slump saleRestructuring
21 Sept 2026Jagsonpal Pharmaceuticals Ltd voting results of 47th AGM held on 18 Sep 2026Record Date
18 Sept 2026Jagsonpal Pharmaceuticals Ltd outcome of 47th AGM held on 18 Sep 2026Record Date
28 Aug 2026Jagsonpal Pharmaceuticals Ltd AGM scheduled on 18 Sep 2026Record Date
28 Aug 2026Jagsonpal Pharmaceuticals Ltd AGM scheduled on 18 Sep 2026Record Date
27 Aug 2026Jagsonpal Pharmaceuticals Ltd letter to shareholders providing web-link to access Annual Report 2025-26 and AGM noticeRecord Date
29 Jul 2026Jagsonpal Pharmaceuticals Ltd fixes record date Sep 04, 2026 for dividend of Rs 4 per shareRecord Date
28 May 2026Jagsonpal Pharmaceuticals Limited Annual Secretarial Compliance Report for FY26 under Regulation 24A scheduled on May 28, 2026Audit Reports
7 May 2026Jagsonpal Pharmaceuticals LtdRecord Date
29 Apr 2026Jagsonpal Pharmaceuticals Limited public announcement for buyback of up to 16,00,000 equity shares at Rs. 250 per share for aggregate consideration of Rs. 40 crores under Regulation 30 with record date May 4, 2026Record Date
28 Apr 2026Jagsonpal Pharmaceuticals Limited announces shareholders' approval for buyback of equity shares under Regulation 30 on April 27, 2026Record Date
28 Apr 2026Jagsonpal Pharmaceuticals Limited record date intimation for buyback of up to 16,00,000 equity shares at ₹250 per share under Regulation 42 scheduled on May 04, 2026Record Date
28 Apr 2026Jagsonpal Pharmaceuticals Limited dividend recommendation of Rs. 4/- (200%) per equity share for FY26 under Regulation 30 announced on April 27, 2026Record Date
21 Apr 2026Jagsonpal Pharmaceuticals Limited board meeting intimation for Q4FY26 under Regulation 29 scheduled on April 27, 2026Record Date
